Amgen Inc. (AMGN, News, Press Releases: 56.78 -0.65 -1.13%, yield: N/A, cap: 55.605B, 1yr target: 68.76) is the world’s largest independent biotechnology medicines company. They discover, develop, manufactures and market medicines for serious illnesses. Their focus is on human therapeutics and AMGN concentrates on medicines based on advances in cellular and molecular biology. 2009 R&D [...]